K

E

KAPITEIJN , Ellen

Last name: KAPITEIJN

First name: Ellen

2018 (v1)

Publication

Metadata-only

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations

Helgadottir, Hildur Ghiorzo, Paola van Doorn, Remco

Inherited CDKN2A mutation is a strong risk factor for cutaneous melanoma. Moreover, carriers have been found to have poor melanoma-specific survival. In this study, responses to novel immunotherapy agents in CDKN2A mutation carriers with metastatic melanoma were evaluated.

Uploaded on: April 14, 2023